Whereas CD43 proficient mice showed the anticipated therapeutic efficacy of PDOX treatment upon tumor challenge, mice deficient in CD43 could not control MC-38 tumor outgrowth despite PDOX treatment (Figure 7G). The gene discussed is SPN; the disease is neoplasm.